Integrity CE
M

Expert Panel Case Discussion: 45 y/o With Recurrent Stage 3A Platinum-Resistant High-Grade Ovarian Cancer

By Integrity CE FEATURING Martina Murphy, Eleonora Teplinsky, Mollie Finkel
By Integrity CE FEATURING Martina Murphy, Eleonora Teplinsky, Mollie Finkel
0 views
January 24, 2024
Comments 1
Login to view comments. Click here to Login

Recommended

AUTOPLAY
25:10
Yale School of Medicine

Ovarian Cancer Prevention and Early Detection - Ovarian Cancer Does …

Feat. M. Minkin, E. Ratner
14:05
Insights from 2023 ESGO Annual Meeting

ESGO 2023 Insights: "ICON8B: GCIG Phase 3 Randomised Trial Comp…

Feat. A. Clamp
13:04
Nebraska Oncology Society

Updates in Ovarian Cancer: Risk Reduction Strategies and Mirvetuxima…

Feat. M. Clark
09:47
Total Health

2023 ASCO® Direct Philadelphia: Phase 3 OVHIPEC-1 Trial Final Surviv…

Feat. A. Smith
06:48
SGO 2023 Conference Coverage on VuMedi

SGO 2023 Phase 3 UP-NEXT Trial: Upifitamab Rilsodotin, a NaPi2b-Dire…

Feat. D. Richardson
13:21
Insights from 2024 ESMO Gynaecological Cancers Congress

The Role of Surgery in Stage IV Ovarian Cancer

Feat. C. Fotopoulou
05:52
Integrity CE

Expert Panel Case Discussion: Stage 4A High-Grade Serous Epithelial …

Feat. M. Murphy, E. Teplinsky, M. Finkel
13:59
Yale Cancer Center

Updates in Gynecologic Cancers: Ovarian Cancer

Feat. M. Clark
18:37
Ovarian Cancer Midwest Focus, University of Minnesota

Role of Zinc Finger Protein 217 (ZNF217) in Ovarian Cancer Metastasis

Feat. A. Padmanabhan
10:21
Penn Medicine Abramson Cancer Center

Detection of Residual Peritoneal Metastases Following Cytoreductive …

Feat. P. Wagner
15:50
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on PARPi in Ovarian Cancer: Is BRCA Related to Ther…

Feat. S. Temkin